Clinical Trial Update: Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial to evaluate whether high-dose chemotherapy followed by autologous stem cell transplantation improves survival in peripheral T-cell lymphoma patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Large Cell Lymphoma Alk-negative
• Angioimmunoblastic T-cell Lymphoma
• Follicular Helper T-cell Lymphoma
• Peripheral T-cell Lymphoma Not Otherwise Specified

Drugs mentioned

• Autologous stem cell transplantation (autologous stem cell transplantation)
• High-dose chemotherapy (high-dose chemotherapy)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Anaplastic Large Cell Lymphoma, ALK-Negative, Follicular Helper T-Cell Lymphoma | Phase 3 | Status: NOT_YET_RECRUITING